Breaking News Instant updates and real-time market news.

JBLU

JetBlue

$15.06 /

+2.71 (+21.94%)

10:05
11/09/20
11/09
10:05
11/09/20
10:05

JetBlue call volume above normal and directionally bullish

Bullish option flow detected in JetBlue with 25,659 calls trading, 21x expected, and implied vol increasing almost 7 points to 68.12%. Nov-20 16 calls and Jan-21 15 calls are the most active options, with total volume in those strikes near 9,900 contracts. The Put/Call Ratio is 0.08. Earnings are expected on January 28th.

JBLU JetBlue
$15.06 /

+2.71 (+21.94%)

10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
JPMorgan double upgrades JetBlue to Overweight on cost controls
10/07/20 JPMorgan
JetBlue upgraded to Overweight from Underweight at JPMorgan
09/08/20 Morgan Stanley
JetBlue initiated with an Overweight at Morgan Stanley

TODAY'S FREE FLY STORIES

Syndicate
Vision Marine Technologies opens at $11.03, IPO priced at $10.00  10:51
11/24/20
11/24
10:51
11/24/20
10:51
VMAR

Vision Marine Technologies

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 24
    Nov
General news
Today's U.S. reports » 10:50
11/24/20
11/24
10:50
11/24/20
10:50

Today's U.S. reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Vision Marine Technologies indicated to open at $12.05, IPO priced at $10.00 » 10:47
11/24/20
11/24
10:47
11/24/20
10:47
VMAR

Vision Marine Technologies

$0.00 /

+ (+0.00%)

Vision Marine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 24
    Nov
Options
Nikola call volume above normal and directionally bullish » 10:45
11/24/20
11/24
10:45
11/24/20
10:45
NKLA

Nikola

$35.81 /

+6.42 (+21.84%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$35.81 /

+6.42 (+21.84%)

NKLA Nikola
$35.81 /

+6.42 (+21.84%)

11/19/20 Loop Capital
Loop Capital starts Nikola at Buy on 'attractive' intellectual property
11/19/20 Loop Capital
Nikola initiated with a Buy at Loop Capital
11/10/20 JPMorgan
Nikola's 'mild positives' in Q3 won't matter to investors, says JPMorgan
11/10/20 Deutsche Bank
Nikola Q3 unlikely to change investor sentiment, says Deutsche Bank
NKLA Nikola
$35.81 /

+6.42 (+21.84%)

NKLA Nikola
$35.81 /

+6.42 (+21.84%)

NKLA Nikola
$35.81 /

+6.42 (+21.84%)

NKLA Nikola
$35.81 /

+6.42 (+21.84%)

General news
St. Louis Federal Reserve Bank President James Bullard Speech to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
General news
St. Louis Federal Reserve Bank President James Bullard Speech to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
11/24/20
11/24
10:45
11/24/20
10:45
 
Hot Stocks
Genmab will not advance development of enapotamab vedotin after POC data » 10:44
11/24/20
11/24
10:44
11/24/20
10:44
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

Genmab A/S announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

Hot Stocks
Bristol-Myers Squibb CVR rallies as FDA resumes domestic inspections » 10:43
11/24/20
11/24
10:43
11/24/20
10:43
BMY-R

Bristol-Myers Squibb CVR

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$62.80 /

+0.88 (+1.42%)

FDA Commissioner Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

Hot Stocks
Genmab says enapotamab vedotin expansion cohorts data didn't meet POC criteria  10:42
11/24/20
11/24
10:42
11/24/20
10:42
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

 
ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

Hot Stocks
Genmab says will not advance development of enapotamab vedotin  10:41
11/24/20
11/24
10:41
11/24/20
10:41
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

 
ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

General news
Oil Action: WTI crude » 10:40
11/24/20
11/24
10:40
11/24/20
10:40

Oil Action: WTI crude has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Ozon indicated to open at $39, IPO priced at $30 » 10:32
11/24/20
11/24
10:32
11/24/20
10:32
OZON

Ozon

$0.00 /

+ (+0.00%)

Ozon (OZON) priced 33M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Nov
Conference/Events
The Wall Street Journal holds WSJ Newsmakers live virtual event » 10:30
11/24/20
11/24
10:30
11/24/20
10:30

The Wall Street…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Treasury Action: the rally's on in equities and the surge in risk appetite is weighing on Treasuries » 10:30
11/24/20
11/24
10:30
11/24/20
10:30

Treasury Action: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Piper reiterates Overweight rating on Alnylam after Oxlumo approved » 10:27
11/24/20
11/24
10:27
11/24/20
10:27
ALNY

Alnylam

$126.70 /

+3.715 (+3.02%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

Options
Bank of America call volume above normal and directionally bullish » 10:25
11/24/20
11/24
10:25
11/24/20
10:25
BAC

Bank of America

$28.40 /

+1 (+3.65%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

10/06/20 JPMorgan
Bank of America price target raised to $27.50 from $26 at JPMorgan
09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 10:25
11/24/20
11/24
10:25
11/24/20
10:25

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Morgan Stanley healthcare analysts to hold analyst/industry conference call » 10:25
11/24/20
11/24
10:25
11/24/20
10:25

Healthcare Distribution…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
10X Capital Venture Acquisition opens at $10, IPO priced at $10 per unit » 10:22
11/24/20
11/24
10:22
11/24/20
10:22
VCVC

10X Capital Venture Acquisition

$0.00 /

+ (+0.00%)

10X Capital Venture…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Tiga Acquisition opens for trade at $10.20, IPO priced at $10 » 10:20
11/24/20
11/24
10:20
11/24/20
10:20
TINV

Tiga Acquisition

$0.00 /

+ (+0.00%)

Tiga Acquisition priced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
The Bank of Finland to hold a webinar » 10:17
11/24/20
11/24
10:17
11/24/20
10:17

Federal Reserve Bank of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.